17-5386260-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_002532.6(NUP88):āc.2172T>Cā(p.His724=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.417 in 1,607,144 control chromosomes in the GnomAD database, including 148,408 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.45 ( 16313 hom., cov: 32)
Exomes š: 0.41 ( 132095 hom. )
Consequence
NUP88
NM_002532.6 synonymous
NM_002532.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 3.54
Genes affected
NUP88 (HGNC:8067): (nucleoporin 88) The nuclear pore complex is a massive structure that extends across the nuclear envelope, forming a gateway that regulates the flow of macromolecules between the nucleus and the cytoplasm. Nucleoporins, a family of 50 to 100 proteins, are the main components of the nuclear pore complex in eukaryotic cells. The protein encoded by this gene belongs to the nucleoporin family and is associated with the oncogenic nucleoporin CAN/Nup214 in a dynamic subcomplex. This protein is also overexpressed in a large number of malignant neoplasms and precancerous dysplasias. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2016]
RABEP1 (HGNC:17677): (rabaptin, RAB GTPase binding effector protein 1) Enables protein domain specific binding activity and protein homodimerization activity. Involved in vesicle-mediated transport. Located in endocytic vesicle and endosome. Part of protein-containing complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.62).
BP6
Variant 17-5386260-A-G is Benign according to our data. Variant chr17-5386260-A-G is described in ClinVar as [Benign]. Clinvar id is 1327042.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=3.55 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.816 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NUP88 | NM_002532.6 | c.2172T>C | p.His724= | synonymous_variant | 17/17 | ENST00000573584.6 | |
RABEP1 | NM_004703.6 | c.*3037A>G | 3_prime_UTR_variant | 18/18 | ENST00000537505.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NUP88 | ENST00000573584.6 | c.2172T>C | p.His724= | synonymous_variant | 17/17 | 1 | NM_002532.6 | P1 | |
RABEP1 | ENST00000537505.6 | c.*3037A>G | 3_prime_UTR_variant | 18/18 | 1 | NM_004703.6 | P1 |
Frequencies
GnomAD3 genomes AF: 0.452 AC: 68536AN: 151782Hom.: 16290 Cov.: 32
GnomAD3 genomes
AF:
AC:
68536
AN:
151782
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.470 AC: 116930AN: 248898Hom.: 30009 AF XY: 0.471 AC XY: 63390AN XY: 134508
GnomAD3 exomes
AF:
AC:
116930
AN:
248898
Hom.:
AF XY:
AC XY:
63390
AN XY:
134508
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.413 AC: 600816AN: 1455244Hom.: 132095 Cov.: 31 AF XY: 0.418 AC XY: 302980AN XY: 724014
GnomAD4 exome
AF:
AC:
600816
AN:
1455244
Hom.:
Cov.:
31
AF XY:
AC XY:
302980
AN XY:
724014
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.452 AC: 68612AN: 151900Hom.: 16313 Cov.: 32 AF XY: 0.465 AC XY: 34543AN XY: 74222
GnomAD4 genome
AF:
AC:
68612
AN:
151900
Hom.:
Cov.:
32
AF XY:
AC XY:
34543
AN XY:
74222
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2604
AN:
3476
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Fetal akinesia deformation sequence 4 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 05, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at